Prediction of necrosis after chemotherapy of advanced germ cell tumors: Results of a prospective multicenter trial of the German Testicular Cancer Study Group

Journal of Urology

Volumn 171, Issue 5, 2004, Pages 1835-1838

  Albers, Peter ^a,i   Weissbach, Lothar ^b   Krege, Susanne ^c   Kliesch, Sabine ^d   Hartmann, Michael ^e   Heidenreich, Axel ^f   Walz, Peter ^g   Kuczyk, Markus ^h   Fimmers, Rolf ^a  

^a UNIVERSITY OF BONN   (Germany)

^b VIVANTES KLINIKUM AM URBAN   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e Military Hospital   (Germany)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

^g Kreiskrankenhaus Lüdenscheid   (Germany)

^h LEIBNIZ UNIVERSITY HANNOVER   (Germany)

ⁱ KLINIKUM KASSEL   (Germany)

Author keywords

Drug therapy; Germinoma; Histology; Prognosis; Surgery

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ACCURACY; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; GERM CELL TUMOR; GERMANY; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; PATIENT SELECTION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SEMINOMA; SENSITIVITY AND SPECIFICITY; TERATOMA; TESTIS CANCER; TREATMENT INDICATION; TUMOR NECROSIS; TUMOR VOLUME;

EID: 4444341868     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000119121.36427.09     Document Type: Article

References (21)

1. Fossa, S. D., Qvist, H., Stenwig, A. E., Lien, H. H., Ous, S. and Giercksky, K. E.: Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses? J Clin Oncol, 10: 569, 1992
2. Debono, D. J., Heilman, D. K., Einhorn, L. H. and Donohue, J. P.: Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol, 15: 1455, 1997
3. Stenning, S. P., Parkinson, M. C., Fisher, C., Mead, G. M., Cook, P. A., Fossa, S. D. et al: Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party. Cancer, 83: 1409, 1998
4. Sheinfeld, J. and Herr, H. W.: Role of surgery in management of germ cell tumor. Semin Oncol, 25: 203, 1998
5. Hendry, W. F., Norman, A. R., Dearnaley, D. P., Fisher, C., Nicholls, J., Huddart, R. A. et al: Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses. Cancer, 94: 1668, 2002
6. Foster, R. S. and Donohue, J. P.: Can retroperitoneal lymphadenectomy be omitted in some patients after chemotherapy? Urol Clin North Am, 25: 479, 1998
7. Steyerberg, E. W., Keizer, H. J., Fossa, S. D., Sleijfer, D. T., Toner, G. C., Schraffordt Koops, H. et al: Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol, 13: 1177, 1995
8. Vergouwe, Y., Steyerberg, E. W., Foster, R. S., Habbema, J. D. and Donohue, J. P.: Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer. J Urol, 165: 84, 2001
9. Hilton, S., Herr, H. W., Teitcher, J. B., Begg, C. B. and Castellino, R. A.: CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR Am J Roentgenol, 169: 521, 1997
10. Fléchon, A., Bompas, E., Biron, P. and Droz, J.-P.: Management of post-chemotherapy residual masses in advanced seminoma. J Urol, 168: 1975, 2002
11. De Santis, M., Bokemeyer, C., Becherer, A., Stoiber, F., Oechsle, K., Kletter, K. et al: Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma. J Clin Oncol, 19: 3740, 2001
12. Mosharafa, A. A., Foster, R. S., Leibovich, B. C., Bihrle, R., Johnson, C. and Donohue, J. P.: Is the post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol, 169: 2126, 2003
13. Baniel, J., Foster, R. S., Rowland, R. G., Bihrle, R. and Donohue, J. P.: Complications of primary retroperitoneal lymph node dissection. J Urol, 152: 424, 1994
14. Baniel, J., Foster, R. S., Rowland, R. G., Bihrle, R. and Donohue, J. P.: Complications of post-chemotherapy retroperitoneal lymph node dissection. J Urol, 153: 976, 1995
15. Heidenreich, A., Albers, P., Hartmann, M., Kliesch, S., Köhrmann, K.-U., Krege, S. et al: Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol, 169: 1710, 2003
16. Steyerberg, E. W., Keizer, H. J. and Habbema, J. D.: Prediction models for the histology of residual masses after chemotherapy for metastatic testicular cancer. ReHiT Study Group. Int J Cancer, 83: 856, 1999
17. Lutke Holzik, M. F., Hoekstra, H. J., Mulder, N. H., Suurmeijer, A. J., Sleijfer, D. T. and Gietema, J. A.: Non-germ cell malignancy in residual or recurrent mass after chemotherapy for nonseminomatous testicular germ cell tumor. Ann Surg Oncol, 10: 131, 2003
18. Fizazi, K., Tjulandin, S., Salvioni, R., Germa-Lluch, J. R., Bouzy, J., Ragan, D. et al: Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy-results from an international study group. J Clin Oncol, 19: 2647, 2001
19. Donohue, J. P., Rowland, R. G., Kopecky, K., Steidle, C. P., Geier, G., Ney, K. G. et al: Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol, 137: 1176, 1987
20. Toner, G. C., Panicek, D. M., Heelan, R. T., Geller, N. L., Lin, S. Y., Bajorin, D. et al: Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol, 8: 1683, 1990
21. Oldenburg, J., Alfsen, G. C., Lien, H. H., Aass, N., Waehre, H. and Fossa, S. D.: Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol, 21: 3310, 2003